osimertinib,blu-945
blueprint medicines,astrazeneca,roche
['blu-945', 'lcsm,(-blcsm)', 'osimertinib', 'symphony', 'nsclc', 'sclc']
blu-945, 4th generation egfr tki, in monotherapy and in combination with osimertinib in previously treated patients with advanced egfr-mutant nsclc (phase 1/2 symphony study) #asco23 #lcsm 
Medical Oncology 🏥 Hospital General Universitario Gregorio Marañón⎪@myESMO Faculty 🫁 ⎪Power to the patients #endlungcancer #lcsm